RxDoctor Payments Data

Kelli Norman

Physician Assistant · du Bois, PANPI 1932262557

Payments from drug & device makers

$708in general payments, 2019–2025

Across 37 payments — averaging $19.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$168
  • AstraZeneca$124
  • Novo Nordisk$92
  • Pfizer$91
  • Amgen$63
  • Exact Sciences$58
  • plus $112 from 5 others

What the payments were for

  • Food & beverage$708100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$708 in reported general payments places this provider in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

See all physician assistant providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$18,522
Medicare patients
138
Services billed
252

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$65,998
EliquisApixaban47$45,780
XareltoRivaroxaban41$40,514
Victoza 3-PakLiraglutide15$20,702
TradjentaLinagliptin24$19,221
JardianceEmpagliflozin13$14,008
MyrbetriqMirabegron30$13,511
Fluticasone-SalmeterolFluticasone Propion/Salmeterol23$8,765
Trelegy ElliptaFluticasone/Umeclidin/Vilanter12$8,613
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$8,429
Atorvastatin Calcium539$7,679
NexiumEsomeprazole Magnesium14$6,498
Jentadueto XrLinagliptin/Metformin Hcl11$5,314
Incruse ElliptaUmeclidinium Bromide15$5,138
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog13$4,367

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$92$65,99866 claims
PfizerEliquis$91$45,78047 claims
GSKTrelegy Ellipta, Incruse Ellipta$31$13,75127 claims
Astellas Pharma US IncMyrbetriq$16$13,51130 claims
AstraZenecaNexium$124$6,49814 claims
AbbVieSynthroid$168$1,78734 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 6,643 physician assistant providers in Pennsylvania.

Other physician assistant in du Bois

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →